ArticleThe oncologist2016

Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer.

David D Stenehjem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.